FCA Federal
This archive displays posts tagged as relevant to the federal False Claims Act. You may also be interested in the following pages:
October 2, 2023
Genomic Health, Inc. (GHI), a wholly-owned subsidiary of Exact Sciences Corporation that provides clinical diagnostic tests, has agreed to pay $32.5 million to resolve two separate qui tam suits alleging violations of the False Claims Act and Anti-Kickback Statute in connection with lab tests for cancer patients. GHI allegedly evaded Medicare’s 14-Day Rule—which prohibits labs from separately billing for the same covered tests within 14 days of a patient’s discharge from a hospital—by canceling and reordering tests so they fell within appropriate time frames, seeking reimbursement directly from Medicare, and writing off unpaid lab fees owed by hospitals. As a result of this settlement, the whistleblowers in the case will receive over $5.5 million. DOJSeptember 30, 2023
The Cigna Group has agreed to pay over $172 million and enter into a five-year Corporate Integrity Agreement in order to resolve allegations of violating the False Claims Act. According to qui tam suit by a former part-owner of a Cigna vendor, Robert Cutler—who will receive an $8.1 million share of the settlement—the healthcare company knowingly submitted inaccurate and untruthful diagnosis codes on behalf of Medicare Advantage Plan beneficiaries in order to inflate their reimbursements from Medicare. DOJNurse Practitioner Convicted in $200 Million Medicare Fraud Scheme
Posted 09/28/23
September 28, 2023
The Boeing Company has agreed to pay $8.1 million to resolve allegations of violating the False Claims Act. Under a Navy contract to manufacture a tiltrotor military aircraft, Boeing allegedly failed to comply with certain manufacturing specifications, submitted false claims, and made false statements. The claims were brought in a qui tam suit by former Boeing employees, who will receive a relator’s share of $1.5 million as a result of the settlement. DOJCatch of the Week: Gramercy Cardiac Diagnostic Services
Posted 09/26/23
September 15, 2023
Navmar Applied Sciences Corp. has agreed to pay $4.4 million to resolve allegations of double billing and improperly shifting costs between contracts, in violation of Federal Acquisition Regulations and the False Claims Act. While under a series of Navy contracts to manufacture, design, and test emerging intelligence technologies, the company double billed for the same costs on two separate contracts, and improperly shifted costs incurred under some contracts to other contracts. DOJGAO Highlights Massive Fraud of Government Funds for Unemployment Insurance During COVID Pandemic
Posted 09/14/23
